Clostridium infection
Drug research and approvals for clostridium infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 46 studies of clostridium infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 46
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For…NCT07894055 · Phase 2 · Changchun BCHT Biotechnology Co. · starts Aug 12, 2026
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated…NCT07891104 · Phase 1 / Phase 2 · Institute of Medical Biology, Chinese Academy of Medical Sciences · starts Oct 11, 2026
- Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal AdenocarcinomaNCT07828236 · Phase 1 · Loki Therapeutics, Inc. · starts Oct 15, 2026
- Study of BK1803 in Healthy InfantsNCT07793513 · Phase 3 · Tanabe Pharma Corporation · starts Oct 21, 2026
- A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides…NCT07649096 · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID) · starts Nov 12, 2026
- Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)NCT07613645 · Not applicable · University of Michigan · starts Jun 5, 2026
- ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile InfectionNCT07513285 · Phase 2 · Acurx Pharmaceuticals Inc. · starts Sep 25, 2026
- Tetanus Severity Score for Prediction of Mortality in Manifest TetanusNCT07512167 · Not reported · Ain Shams University · starts Apr 15, 2026
- FMT Capsules for rCDINCT07458984 · Phase 3 · Helsinki University Central Hospital · starts Apr 25, 2026
How its trials ended
300 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 123 whose ending is known, 42% met their primary endpoint, 4% missed it and 54% stopped early.
- Completed, result not reported9431%
- Met its primary endpoint5217%
- Ongoing4916%
- Status unknown3411%
- Stopped: other or unclear3211%
- Stopped: enrollment or feasibility186%
- Stopped: funding62%
- Missed its primary endpoint52%
- Stopped: lack of efficacy52%
- Stopped: sponsor or business decision52%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA